Biochemical markers in the assessment of bone disease

被引:60
作者
Bikle, DD [1 ]
机构
[1] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
关键词
D O I
10.1016/S0002-9343(97)00137-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As the mean age of our population increases, increasing attention has been paid to the diseases associated with aging, including diseases of the skeleton such as osteoporosis. Effective means of treating and possibly preventing such skeletal disorders are emerging, making their early recognition an important goal for the primary care physician. Although bone density measurements and skeletal imaging studies remain of primary diagnostic importance in this regard, a large number of assays for biochemical markers of bone formation and resorption are being developed that promise to complement the densitometry measurements and imaging studies, providing an assessment of the rates of bone turnover and an earlier evaluation of the effects of therapy. In this review, emphasizing the recent literature, the major biochemical markers currently in use or under active investigation are described, and their application in a number of diseases of the skeleton including osteoporosis is evaluated. (C) 1997 by Excerpta Medica, Inc.
引用
收藏
页码:427 / 436
页数:10
相关论文
共 72 条
[1]   EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS [J].
ADAMI, S ;
PASSERI, M ;
ORTOLANI, S ;
BROGGINI, M ;
CARRATELLI, L ;
CARUSO, I ;
GANDOLINI, G ;
GNESSI, L ;
LAURENZI, M ;
LOMBARDI, A ;
NORBIATO, G ;
PRYORTILLOTSON, S ;
REDA, C ;
ROMANINI, L ;
SUBRIZI, D ;
WEI, L ;
YATES, AJ .
BONE, 1995, 17 (04) :383-390
[2]  
ALVAREZ L, 1995, J BONE MINER RES, V10, P458
[3]   OSTEOCALCIN - IS IT A USEFUL MARKER OF BONE METASTASIS AND RESPONSE TO TREATMENT IN ADVANCED PROSTATE-CANCER [J].
ARAI, Y ;
TAKEUCHI, H ;
OISHI, K ;
YOSHIDA, O .
PROSTATE, 1992, 20 (03) :169-177
[4]  
ARBAULT P, 1995, BONE, V16, P461
[5]   Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis [J].
Bettica, P ;
Taylor, AK ;
Talbot, J ;
Moro, L ;
Talamini, R ;
Baylink, DJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (02) :542-546
[6]   APPLICATIONS OF AN ENZYME-IMMUNOASSAY FOR A NEW MARKER OF BONE-RESORPTION (CROSSLAPS) - FOLLOW-UP ON HORMONE REPLACEMENT THERAPY AND OSTEOPOROSIS RISK ASSESSMENT [J].
BONDE, M ;
QVIST, P ;
FLEDELIUS, C ;
RIIS, BJ ;
CHRISTIANSEN, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :864-868
[7]   INFLUENCE OF AGE, SEX, AND INSULIN ON OSTEOBLAST FUNCTION - OSTEOBLAST DYSFUNCTION IN DIABETES-MELLITUS [J].
BOUILLON, R ;
BEX, M ;
VANHERCK, E ;
LAUREYS, J ;
DOOMS, L ;
LESAFFRE, E ;
RAVUSSIN, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1194-1202
[8]   ASSESSMENT OF BONE-FORMATION BY BIOCHEMICAL MARKERS IN METABOLIC BONE-DISEASE - SEPARATION BETWEEN OSTEOBLASTIC ACTIVITY AT THE CELL AND TISSUE-LEVEL [J].
CHARLES, P ;
HASLING, C ;
RISTELI, L ;
RISTELI, J ;
MOSEKILDE, L ;
ERIKSEN, EF .
CALCIFIED TISSUE INTERNATIONAL, 1992, 51 (06) :406-411
[9]   ASSESSMENT OF BONE REMODELING USING BIOCHEMICAL INDICATORS OF TYPE-I COLLAGEN-SYNTHESIS AND DEGRADATION - RELATION TO CALCIUM KINETICS [J].
CHARLES, P ;
MOSEKILDE, L ;
RISTELI, L ;
RISTELI, J ;
ERIKSEN, EF .
BONE AND MINERAL, 1994, 24 (02) :81-94
[10]   ALENDRONATE TREATMENT OF THE POSTMENOPAUSAL OSTEOPOROTIC WOMAN - EFFECT OF MULTIPLE DOSAGES ON BONE MASS AND BONE REMODELING [J].
CHESTNUT, CH ;
MCCLUNG, MR ;
ENSRUD, KE ;
BELL, NH ;
GENANT, HK ;
HARRIS, ST ;
SINGER, FR ;
STOCK, JL ;
YOOD, RA ;
DELMAS, PD ;
KHER, U ;
PRYORTILLOTSON, S ;
SANTORA, AC .
AMERICAN JOURNAL OF MEDICINE, 1995, 99 (02) :144-152